Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Baird Initiates Coverage On American Healthcare REIT with Outperform Rating, Announces Price Target of $41

Author: Benzinga Newsdesk | July 18, 2025 07:02am
Baird analyst Wesley Golladay initiates coverage on American Healthcare REIT (NYSE:AHR) with a Outperform rating and announces Price Target of $41.

Posted In: AHR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist